HEPLISAV™ efficacy in the Hep B #vaccine field

Dr J Tyler Martin, President, CMO & Director, DynaVax joined us a few weeks ago at the 12th annual World Vaccine Congress in Washington DC to discuss his views on HEPLISAVâ„¢ efficacy in the Hep B vaccine field. Dr J Tyler Martin talked us through the unmet needs in Hepatitis B Vaccination: • Existing vaccines require ~6 months for protection …